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OBJECTIVE—Glucose sensing by specialized neurons of the
hypothalamusisvitalfornormalenergybalance.Inmanyglucose-
activated neurons, glucose metabolism is considered a critical
step in glucose sensing, but whether glucose-inhibited neurons
follow the same strategy is unclear. Orexin/hypocretin neurons
of the lateral hypothalamus are widely projecting glucose-
inhibited cells essential for normal cognitive arousal and feeding
behavior. Here, we used different sugars, energy metabolites, and
pharmacological tools to explore the glucose-sensing strategy of
orexin cells.
RESEARCH DESIGN AND METHODS—We carried out patch-
clamp recordings of the electrical activity of individual orexin
neurons unambiguously identiﬁed by transgenic expression of
green ﬂuorescent protein in mouse brain slices.
RESULTS—We show that 1) 2-deoxyglucose, a nonmetaboliz-
able glucose analog, mimics the effects of glucose; 2) increasing
intracellular energy fuel production with lactate does not repro-
duce glucose responses; 3) orexin cell glucose sensing is unaf-
fected by glucokinase inhibitors alloxan, D-glucosamine, and
N-acetyl-D-glucosamine; and 4) orexin glucosensors detect man-
nose, D-glucose, and 2-deoxyglucose but not galactose, L-glucose,
-methyl-D-glucoside, or fructose.
CONCLUSIONS—Our new data suggest that behaviorally criti-
cal neurocircuits of the lateral hypothalamus contain glucose
detectors that exhibit novel sugar selectivity and can operate
independently of glucose metabolism. Diabetes 57:2569–2576,
2008
H
ypothalamic neurons maintain body energy bal-
ance by sensing energy status and initiating
compensatory adjustments in food intake and
energy expenditure (1,2). A key signal inform-
ing the brain of energy levels is the concentration of
extracellular glucose (3,4). Specialized glucose-sensing
(glucosensing) hypothalamic neurons respond to changes
in ambient glucose levels with increases (glucose-excited
neurons) or decreases (glucose-inhibited neurons) in their
ﬁring frequency (5,6). These responses are considered
critical for orchestrating changes in hormone release,
appetite, and food-seeking behavior that control body
energy stores and blood glucose levels (4,7,8). Impaired
hypothalamic glucosensing can lead to diabetes and obe-
sity (9). It is thus important to understand how gluco-
sensing neurons operate.
Until now, most studies examining the link between
ﬂuctuations in glucose levels and neuronal electrical ac-
tivity have focused on glucose-excited neurons. There is
now strong evidence that in most of these cells, extracel-
lular glucose is carried into the cytosol by GLUT, phos-
phorylated by glucokinase, and subsequently metabolized
to generate ATP, which closes membrane ATP-sensitive
K
 channels (KATP channels) and so electrically excites
the cell (7,8,10). In contrast, glucose-inhibited neurons
remain much less understood. Although the ﬁnal effectors
mediating glucose-induced inhibition have been recently
deﬁned as K
 or Cl
 channels (11,12), the nature of
glucosensing events upstream of these channels is un-
clear. There are some indirect indications that glucokinase
is involved, for example, treatment of hypothalamic cell
cultures with small interfering glucokinase mRNA accel-
erates the natural decline in their ability to exhibit glucose-
induced inhibition (13). However, glucokinase appears to
be found at low or undetectable levels in some glucosens-
ing neurons (14), suggesting that other glucosensing
modes are possible.
Clearly resolving the role of glucose metabolism in
glucose-induced inhibition of behaviorally deﬁned neuro-
circuits requires direct measurements of electrical re-
sponses in functionally deﬁned neurons. Recently, it
became clear that lateral hypothalamic neurons containing
the neuropeptides orexins/hypocretins (orexin neurons)
(15,16) are inhibited by glucose because of sugar-induced
opening of postsynaptic K
 channels (11,17). Orexin neu-
rons are an excellent model for studying glucose-induced
inhibition because they are readily identiﬁable in living
brain slices by targeted expression of ﬂuorescent proteins
(17). Furthermore, changes in their electrical activity have
well-deﬁned physiological and behavioral implications.
Through widespread projections to diverse brain areas
expressing speciﬁc orexin receptors coupled to neuronal
excitation, the ﬁring of orexin neurons stimulates wake-
fulness, metabolic rate, and food intake (18,19). Orexin
neurons are so critical for stable consciousness that their
loss causes narcolepsy in a variety of mammalian species
(20–22). Furthermore, key roles for orexins are emerging
in reward-seeking and addiction (23,24). Understanding
glucose responses of orexin cells would thus provide
fundamental information about brain glucosensing in the
context of vital adaptive behaviors.
To examine whether glucose metabolism is involved in
glucosensing mediated by orexin cells, we directly mea-
sured their electrical responses to metabolizable and
nonmetabolizable sugars, to stimulation of intracellular
ATP production with lactate, and to glucokinase inhibi-
tors. Our results suggest that sugar sensing in orexin
neurons is independent of glucose metabolism or intra-
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selectivity signature indicative of a novel glucose receptor.
RESEARCH DESIGN AND METHODS
Preparation of brain slices from transgenic mice. Animal procedures
were performed according to the Animals (Scientiﬁc Procedures) Act, 1986
(U.K.). Transgenic “orexin-eGFP” mice were used in all experiments to
identify orexin neurons, as in our previous studies (11,25). These mice
expressed enhanced green ﬂuorescent protein (eGFP) under the control of the
prepro-orexin promoter, resulting in very speciﬁc targeting of eGFP only to
orexin neurons (11). Mice were maintained on a 12-h light:dark cycle (lights
on at 08:00 h) and had free access to food and water. Animals (14–21 days
postnatal) were killed during the light phase. Coronal slices (250–300 m
thick) containing the lateral hypothalamus were cut with a Campden Vibro-
slice in ice-cold extracellular solution, incubated at 35°C in carbogen-gassed
extracellular solution for 30 min, and then kept at room temperature until
recording, as previously described (26). Typically, between 5 and 20 cells were
evaluated from each animal used.
Chemicals and solutions. The extracellular solution was gassed with 95% O2
and 5% CO2 and contained 125 mmol/l NaCl, 2.5 mmol/l KCl, 2 mmol/l MgCl2,
2 mmol/l CaCl2, 1.2 mmol/l NaH2PO4, 21 mmol/l NaHCO3, and 1 mmol/l
glucose, except where indicated otherwise. We used a “K-chloride” intracel-
lular (pipette) solution throughout to reduce junction potential errors in
measurements of current-voltage relationships (27). This solution contained
130 mmol/l KCl, 0.1 mmol/l EGTA, 10 mmol/l HEPES, 5 mmol/l K2ATP, 1
mmol/l NaCl, and 2 mmol/l MgCl2, pH 7.25, with KOH. Where not indicated, the
full chemical names of sugars and metabolites we used were D-()-mannose,
L-lactate, D-()-fructose, D-()-galactose, D-()-glucose, L-()-glucose, and
methyl--D-glucopyranoside. All chemicals were from Sigma (Poole, Dorset,
U.K.). Chemicals were applied extracellularly by bath perfusion, unless
indicated otherwise.
Data acquisition and analysis. Living orexin-eGFP neurons were visualized
in brain slices using an Olympus BX50WI upright microscope equipped with
epiﬂuorescence as previously described (11). Whole-cell recordings, including
switching to voltage-clamp mode (for recording membrane currents) and
current-clamp mode (for recording membrane potential), were performed
using an EPC-10 ampliﬁer (Heka, Lambrecht, Germany) at 36°C (bath tem-
perature controlled with Badcontroller V; Luigs & Neumann). Patch pipettes
were pulled from borosilicate glass and had tip resistances of 3–6 mol/l.
Series resistances were in the range of 5–10 mol/l and were not compen-
sated. Data were sampled and ﬁltered using Patchmaster software (Heka) and
analyzed with custom-written Python software (http://www.python.org), Mat-
plotlib (http://matplotlib.sourceforge.net), and Origin software (Microcal,
Northampton, MA).
To monitor membrane resistance together with changes in membrane
potential (Figs. 1A and 8A–C), cells were injected every 20–40 s with a
ﬁxed-amplitude (10–40 pA, 1-s duration) square pulse of hyperpolarizing
current (26). The amplitude of the resulting downward deﬂections in mem-
brane potential is proportional to membrane resistance (Ohm’s law).
Current-voltage relationships (Figs. 2A and B,3 B,4 B,5 B and C, and 7B and
C) were obtained by performing voltage-clamp ramps from 0 to 140 mV at a
rate of 0.1 mV/ms ramp, which is sufﬁciently slow to allow leak-like K
 currents
to reach steady state at each potential (28). In Figs. 2B and 7C, the net
current-voltage relationship was ﬁtted with the Goldman-Hodgkin-Katz (GHK)









Here, I is current (in A), V is membrane potential (in V), z is the charge of a
potassium ion (1), [K
]i is the pipette K
 concentration (in mmol/l), [K
]o is
the extracellular K
 concentration (in mmol/l), T is temperature (in Kelvins),
and R and F have their usual meanings (29). PK (a constant reﬂecting the K

permeability of the membrane) was the only free parameter during ﬁts. The
values of PK used to obtain the ﬁts shown in Figs. 2B and 7C were,
respectively, 4.616 
 10
17 and 1.554 
 10
17 cm/s. Values are presented as
means  SE.
RESULTS
2-Deoxyglucose mimics the effects of glucose on
orexin neurons. We examined the effects of a variety of
sugars and agents that affect energy metabolism on the
membrane potential and currents of orexin neurons directly
identiﬁed by selective expression of GFP using whole-cell
patch-clamp recordings (11). We ﬁrst tested 2-deoxyglucose,
a nonmetabolizable glucose analog that competes with glu-
cose for binding to enzymes and transporters, thereby acting
as an energy-depleting “antimetabolite.” Thus, we expected
this antimetabolite to have the opposite effects to glucose or
no effects at all, because the cells that we recorded were
provided with ATP from the pipette solution and hence
presumably were energetically independent of extracellular
glucose. However, 2-deoxyglucose mimicked the effects of
glucose on the membrane potential and conductance of
orexin cells, triggering dose-dependent and reversible
membrane hyperpolarization and increase in membrane
conductance (Fig. 1A and B, n  30 cells). Analysis of
membrane current responses to voltage-clamp ramps re-
vealed that the changes in membrane potential were
associated with activation of an ionic current that reversed
at a membrane potential corresponding to EK (Fig. 2A, n 
7 cells; predicted EK 
 100 mV with our solutions) and
followed an outward current-voltage rectiﬁcation well
described by the GHK equation (Fig. 2B, n  4 cells), as
previously described for glucose (11). Like glucose, 2-de-
oxyglucose thus hyperpolarizes the orexin cell membrane
by activating a leak-like K
 current.
We also performed control experiments to ensure that
the effects of 2-deoxyglucose on orexin neurons are a
speciﬁc phenomenon rather than a general outcome of
energy depletion caused by this antimetabolite). First, we
applied 2-deoxyglucose to neurons that had similar mem-
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FIG. 1. Effects of 2-deoxyglucose on the membrane potential of orexin
neurons. A: A GFP-expressing orexin neuron identiﬁed in brain slice by
epiﬂuorescence (full description and validation of the GFP-labeling
method is given by Burdakov et al. [11]) (top). Effects of 5 mmol/l
bath-applied 2-deoxyglucose (2-DG) on membrane potential and resis-
tance (resistance monitored as voltage deﬂections in response to
hyperpolarizing current injections, see RESEARCH DESIGN AND METHODS)
(bottom). B: Effect of 1 mmol/l bath-applied 2-deoxyglucose on mem-
brane potential. C: Magnitudes of membrane potential hyperpolariza-
tion (Vm) induced by 1 and 5 mmol/l 2-deoxyglucose. ***P < 0.005,
values are means  SE, n  4 cells for each condition.
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cortex, a nonglucosensing brain region (6). Unlike in
orexin cells, in cortical neurons, 2-deoxyglucose induced
neither hyperpolarization (Fig. 3A, n  7 cells) nor acti-
vation of K
 currents (Fig. 3B, n  7 cells). Second, we
ﬁlled orexin neurons with 350 mol/l tolbutamide and 5
mmol/l ATP by including these chemicals in the pipette
solution used for whole-cell recording. This procedure is
expected to block their KATP channels by 
100% (30),
thereby disrupting the ubiquitous coupling between intra-
cellular ATP metabolism and membrane potential in neu-
rons (31). Under these conditions, orexin cells still
exhibited full-blown responses to 2-deoxyglucose (Fig. 4A
and B, n  6 cells) and glucose (n  3; data not shown).
In the presence of tolbutamide, hyperpolarization elicited
by 2-deoxyglucose (17.0  2.5 mV, n  6) was not different
from that in control cells (19.9  2.5 mV, n  9, P  0.437).
This implies that orexin cell responses to 2-deoxyglucose
are a speciﬁc sensing phenomenon of orexin cells rather
than a general neuronal response related to energy
metabolism.
Lactate does not mimic the effects of glucose despite
being metabolized. To further examine the effects of
energy metabolism on the membrane potential of orexin
cells, we stimulated them with lactate. Lactate is used as
fuel for mitochondrial ATP production and is considered
to be the preferred energy fuel for central neurons (32).
Lactate (5 mmol/l) neither hyperpolarized orexin neurons
nor activated their K
 currents (Fig. 5A and B). Instead, it
triggered a slight membrane depolarization and an in-
crease in action potential ﬁring frequency, both of which
were reversible upon removal of lactate (Fig. 5A, n  10
cells). To examine membrane currents underlying these
excitatory effects, we looked at membrane current-voltage
relationships before and after lactate action, which re-
vealed that lactate inhibited a membrane current with a
reversal potential close to that of K
 (Fig. 5B, n  4 cells).
This observation is consistent with lactate being converted
to ATP and the latter blocking the KATP channels. We
observed that the net lactate-inhibited current (Fig. 5C,
n  4 cells) exhibited an inward current-voltage rectiﬁca-
tion typical of KATP channels (30) but not of glucose-
activated K
 channels (11). These data imply that in
orexin neurons, lactate-induced stimulation of mitochon-
drial ATP production causes membrane depolarization
through closure of KATP channels and does not mimic the
activating effects of glucose on leak-like K
 channels.
Glucokinase inhibitors do not block glucose re-
sponses. Our experiments with lactate imply that mito-
chondrial ATP generation does not induce glucosensing
responses in orexin cells. However, it is possible that the
exact site of ATP production is critical for glucose-
sensing, for example, in glucose-excited -cells; pyruvate
does not trigger glucosensing responses despite being me-
tabolized (33,34). Therefore, we next tested whether glu-
cosensing depends on glucose metabolism in the glycolytic
pathway. To block glycolytic metabolism of glucose, we
pharmacologically inhibited glucokinase with high con-
centrations of three selective inhibitors, alloxan, D-glu-
cosamine, and N-acetyl-D-glucosamine (35). However, in
orexin neurons, glucokinase inhibition did not change the
effects of glucose on the membrane potential (Fig. 6A–C,
n  14 cells) or K
 currents (n  3 cells for each inhibitor;
data not shown). In the presence of alloxan, D-glu-
A
B
FIG. 2. Effects of 2-deoxyglucose on the membrane currents of orexin
neurons. Whole-cell voltage-clamp recordings. A: Effect of 2-deoxyglu-
cose on membrane current-voltage relationships. B: Current-voltage
relationship of the net current activated by 2-deoxyglucose. The line is
a ﬁt of the GHK equation to the data (see RESEARCH DESIGN AND METHODS).




















FIG. 3. Effects of 2-deoxyglucose on cortical neurons. A: Effect of
2-deoxyglucose on the membrane potential. Breaks in the trace corre-
spond to where the recording was interrupted to expose the cell to
voltage-clamp ramps (see RESEARCH DESIGN AND METHODS). Arrows show
where the voltage-clamp ramps shown in B were taken. B: Effect of
2-deoxyglucose on membrane current-voltage relationship of the cell
shown in A. No activation of K
 current is observed, but 2-deoxyglu-
cose inhibits a current with a reversal potential of about 50 mV.
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switch from 1 to 5 mmol/l glucose caused hyperpolariza-
tion of 21.7  3.7 (n  5), 22.5  3.1 (n  5), and 28.0 
2.4 mV (n  4), which is indistinguishable from control
value (25.1  3.7 mV, n  6; P  0.533, 0.616, and 0.582,
respectively).
These results indicate that preventing intracellular glu-
cose from being converted to its metabolizable form by
glucokinase-catalyzed phosphorylation does not affect the
ability of orexin cells to sense glucose. In fact, intracellular
glucose in general is unlikely to play a key role in orexin
cell glucosensing because artiﬁcial infusion of glucose into
orexin cells does not trigger their inhibitory glucose
responses (11). Here, we repeated the latter experiment
with higher concentrations of intracellular glucose and
lower concentrations of extracellular glucose than in this
original study (Fig. 6D). We found that internally dialyzing
orexin cells with 10 mmol/l glucose does not evoke
glucosensing responses but, subsequently, that switching
from 1 to 2.5 mmol/l glucose outside the same cell elicits
normal responses (Fig. 6D, n  4 cells). Thus, it is unlikely
that glucose-derived energy metabolites or intracellular
glucose plays a role in glucose responses of orexin neurons.
Effects of other sugars on orexin neurons. Despite the
importance of orexin neurons for behavioral coordination,
and the potent inhibitory effects of glucose on these cells,
their sensitivity to other sugars has not been examined.
Determining the sugar selectivity of glucose effects on
orexin neurons can provide valuable information about
the nature of the glucose-detection device in these cells,
because sugar binding sites on known glucose-binding
proteins exhibit speciﬁc sugar-selectivity signatures (see
DISCUSSION). In addition to 2-deoxyglucose (Fig. 1), there-
fore, we examined responses to ﬁve other sugars, mannose,
L-glucose, -methyl-D-glucoside, fructose, and galactose. Of
these, only mannose mimicked the effects of glucose on
the membrane potential of orexin cells (Fig. 7A, n  8
cells). The responses of orexin cells to mannose were also
identical to glucose responses in terms of activation of
membrane currents: Like glucose, mannose triggered a
K-selective current (Fig. 7B, n  6 cells) whose current-
voltage relationship was well approximated by the GHK
current equation (Fig. 7C). In contrast, at 5 mmol/l, none of
the other sugars that we tried affected the membrane
potential (Fig. 8, n  4 cells for each sugar tested) or
membrane currents (n  3 cells for each sugar; data not
shown) of orexin cells. To validate glucose-sensing viabil-
ity of each cell we examined, we stimulated it with 5
mmol/l glucose at the end of the experiment, which
invariably triggered a full-blown hyperpolarizing response
(Fig. 8).
DISCUSSION
In this study, we document several previously unknown
features of sugar-induced block of orexin neurons, cells
FIG. 4. Effects of 2-deoxyglucose on orexin neurons in the presence of
tolbutamide. A: Effect of 2-deoxyglucose on the membrane potential in
the presence of intracellular (pipette) tolbutamide. Arrows show
where the voltage-clamp ramps shown in B were recorded. B: Effect of
2-deoxyglucose on membrane current-voltage relationships of the cell
shown in A. FIG. 5. Effects of lactate on orexin neurons. A: Effect of lactate on the
membrane potential. Arrows show where voltage-clamp ramps shown
in B were taken. B: Effect of lactate on the membrane current-voltage
relationship of the cell shown in A. C: Current-voltage relationship of
the net current inhibited by lactate.
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First, 2-deoxyglucose, a nonmetabolizable glucose analog
causing energy depletion, selectively mimics the inhibitory
effects of glucose (Figs. 1–3). Second, stimulating ATP
generation with lactate does not reproduce the effects of
glucose (Fig. 5). Third, orexin cell glucosensing is not
affected by glucokinase inhibitors, which block glucose
entry into glycolysis (Fig. 6). Fourth, glucose-induced
inhibition of orexin neurons exhibits a unique sugar-
selectivity signature: It is caused by D-glucose, mannose
(Fig. 7), and 2-deoxyglucose (Fig. 1) but not by L-
glucose, galactose, -methyl-D-glucoside, or fructose
(Fig. 8). Together, these data indicate that behaviorally
vital neurocircuits of the lateral hypothalamus contain
pharmacologically novel glucose detectors that can
operate independently of glucose metabolism.
Metabolic and nonmetabolic modes of brain glucose
sensing. To the best of our knowledge, this study is the
ﬁrst direct demonstration of metabolism-independent glu-
cose sensing in glucose-inhibited neurons. Our evidence
for this comes from direct electrophysiological measure-
ments of glucosensing in identiﬁed orexin cells and is





FIG. 6. Effects of glucokinase inhibitors and intracellular glucose on
the glucose response of orexin neurons. A: Effect of 5 mmol/l glucose
on the membrane potential in the presence of 10 mmol/l bath alloxan.
B: Effect of 5 mmol/l glucose on the membrane potential in the
presence of 10 mmol/l bath D-glucosamine. C: Effect of 5 mmol/l glucose
on the membrane potential in the presence of 4 mmol/l bath N-acetyl-
D-glucosamine (NAG). D: Cartoon showing experimental protocol
(top). Effect on the membrane potential of 10 mmol/l interacellular




FIG. 7. Effects of mannose on orexin neurons. A: Effect of 1 mmol/l
mannose on the membrane potential (top). Effect of 4 mmol/l mannose
on the membrane potential (bottom). Arrows show where membrane
ramps shown in B were taken. B: Effect of mannose on membrane
current-voltage relationships of the cell shown in A (bottom). C:
Current-voltage relationship of the net current activated by mannose.
The line is a ﬁt of the GHK equation to the data (see RESEARCH DESIGN
AND METHODS). Values are means  SE, n  6 cells.
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sensing responses by a nonmetabolizable glucose analog
2-deoxyglucose (Figs. 1–3); 2) lack of stimulation of
glucosensing responses by neuronal energy fuel lactate
(Fig. 5); and 3) Insensitivity of glucosensing responses to
suppression of intracellular glucose metabolism to ATP
with glucokinase blockers (Fig. 6). The latter experiment
is an important functional complement to previous work
that suggested that orexin neurons do not express gluco-
kinase mRNA (35), because molecular determination of
glucokinase expression is notoriously difﬁcult.
Glucose-inhibited orexin neurons thus appear to oper-
ate very differently from classical glucose-excited neurons.
In the latter, glucosensing responses are not triggered by
2-deoxyglucose, mimicked by lactate, and abolished by
glucokinase inhibitors (36). This clearly indicates that
glucose-excited neurons need glucose metabolism for
their sugar-sensory activity, and it has been recently
theorized that glucose-inhibited neurons follow a similar
strategy (13,35). However, for glucose-inhibited neurons,
such theories have so far been examined by measuring the
effects of reducing glucokinase mRNA expression on
cytosolic Ca
2 signals in neuronal cultures (13) and by
looking at effects of pharmacological glucokinase inhibi-
tors and activators on spontaneous Ca
2 signals (13,35).
How these data relate to the coupling between extracellu-
lar glucose and membrane currents in situ is difﬁcult to
interpret. On the other hand, direct patch-clamp measure-
ments from glucose-inhibited neurons of the ventromedial
hypothalamus suggested that these cells share at least
some similarities with the orexin neurons analyzed here.
For example, like orexin cells (Fig. 5), the ventromedial
glucose-inhibited neurons are not inhibited by lactate
(37). A comprehensive evaluation of whether energy-
independent glucosensing is found widely in glucose-
inhibited cells requires the development of speciﬁc
markers for identifying glucose-inhibited neurons in
other brain regions, combined with direct measure-
ments of their electrical activity. Currently, our study
indicates that, in glucose-inhibited orexin neurons at
least, conventional glucose metabolism is not required
for sugar sensing.
Substrate selectivity signatures of sugar sensors.
Although the physiological importance of orexin neurons
and their ability to sense glucose have been recognized for
several years, the nature of the glucose detector in orexin
cells remains elusive. Our study provides the ﬁrst phar-
macological characterization of this sugar-sensing de-
vice by examining the effects of other sugars on orexin
cells. For the orexin cell glucosensor, we found activa-
tion by D-glucose, 2-deoxyglucose (Fig. 1), and mannose
(Fig. 7), but not by fructose, D-galactose, -methyl-D-
glucoside, or L-glucose (Fig. 8). Thus, the glucosensing
device in glucose-inhibited orexin cells appears pharma-
cologically distinct from that in glucose-excited neu-
rons, because the latter is activated by galactose but not
by 2-deoxyglucose (36).
The sugar selectivity proﬁle deﬁned here provides im-
portant information about the orexin cell glucose detector
because known glucose-binding proteins exhibit charac-
teristic sugar-selectivity signatures. For example, the glu-
cose transporter protein hSGLT3, which acts as an
extracellular glucose sensor not requiring transport or
metabolism of the sugar for its sensing role, is activated by
glucose and -methyl-D-glucoside but not by galactose,
fructose, or mannitol (38). In contrast, both glucose and
galactose are active substrates of its relative, SGLT1.
Another family of glucose transporters, GLUTs, which can
also operate as glucose receptors independently of their
ability to transport or metabolize sugars (39), exhibit yet
different sugar selectivity. For example, GLUT2, unlike
SGLT3, is activated by fructose. The sugar selectivity of
the orexin cell glucosensor thus appears distinct from
the glucose-binding proteins mentioned above: Unlike
hSGLT3, it is not activated by -methyl-D-glucoside;
unlike SGLT1, it is not activated by galactose; and unlike
GLUT2, it is not activated by fructose. We are not aware
of any glucose-binding proteins that have similar sugar
selectivity to the glucose detector in orexin neurons.
This provides a valuable criterion for future screening of
different glucose-sensing molecules as candidate molec-
ular correlates for the orexin cell glucosensor.
Physiological implications. Here, we studied neuro-
chemically deﬁned orexin neurons, whose physiological
importance in the control of feeding and wakefulness is
well established (19) and whose ﬁring can lead to behav-
ioral alterations if it changes by as little as 5 Hz (18).
Understanding the mechanisms regulating the electrical























FIG. 8. Sugars that were not effective in hyperpolarizing orexin
neurons. A: Lack of effect of 5 mmol/l L-glucose on the membrane
potential and resistance, followed by normal response to 5 mmol/l
glucose. B: Lack of effect of 5 mmol/l -methyl-D-glucoside (-MDG)
on the membrane potential and resistance, followed by normal
response to 5 mmol/l glucose. C: Lack of effect of 5 mmol/l fructose
on the membrane potential and resistance, followed by normal
response to 5 mmol/l glucose. D: Lack of effect of 5 mmol/l galactose
on the membrane potential, followed by normal response to 5 mmol/l
glucose.
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plex brains produce survival advantages by predicting and
then avoiding danger before it becomes disruptive to
bodily functions. The dissociation between sensing and
use of metabolic fuels may allow the brain to sense
glucose levels and to carry out compensatory adjustments
before cellular metabolism is disrupted. It is tempting to
speculate that the energy-independent glucose sensing
described here can occur outside the glucose concentra-
tion range where extracellular glucose affects intracellular
ATP levels. This would enable metabolism-independent
glucose-inhibited neurons to act as “predictive” sensors,
and metabolism-dependent glucose-excited neurons to act
“emergency alarms” signaling dangerously low glucose
levels. Comparisons of glucose sensitivity of lateral
hypothalamic neurons suggest that glucose-inhibited
neurons may sense glucose in a higher concentration
range than glucose-excited neurons (26). Further eluci-
dation of relative roles of glucose-excited and glucose-
inhibited neurons are a key subject for future research.
In this context, our ﬁnding that glucose-inhibited orexin
neurons do not sense galactose (Fig. 8D) offers a
potential new way to discriminate between physiologi-
cal effects of activation of glucose-inhibited versus
glucose-excited neurons, because the latter do sense
galactose (36). For example, a suppression of feeding by
glucose but not galactose (e.g., as reported by Kurata et
al. [40]) may suggest an involvement of glucose-inhib-
ited neurons. Future in vivo studies guided by the
cellular information presented here should provide new
insights into physiological and pathological impact of
different glucosensing neurocircuits.
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